Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 0.96 is in line with its 5-year average of 0.89, near the high end of its 5-year range (-2.46–1.92).
As of the fiscal period ended Tuesday, June 30, 2026. 3.97% below its 12-month average of 1.00.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.96.
QUICK RATIO (ACID-TEST)
0.96
QUICK RATIO (ACID-TEST) AVG TTM
1.00
QUICK RATIO (ACID-TEST) AVG 3Y
0.89
QUICK RATIO (ACID-TEST) AVG 5Y
0.89
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-3.97%
CURRENT VS 3Y AVG
+7.83%
CURRENT VS 5Y AVG
+8.60%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.99
median of 506 covered companies
CURRENT VS SECTOR MEDIAN
-67.84%
vs the sector median at left
Market Cap
$2.07B
Quick Ratio (Acid-Test)
2.29
TTM Avg
2.30
3Y Avg
3.09
5Y Avg
3.45
Market Cap
$2.06B
Quick Ratio (Acid-Test)
6.16
TTM Avg
5.39
3Y Avg
6.60
5Y Avg
7.52
Market Cap
$2.13B
Quick Ratio (Acid-Test)
1.69
TTM Avg
1.73
3Y Avg
1.64
5Y Avg
1.89
Market Cap
$2.04B
Quick Ratio (Acid-Test)
15.08
TTM Avg
9.38
3Y Avg
7.12
5Y Avg
8.07
Market Cap
$2.03B
Quick Ratio (Acid-Test)
4.97
TTM Avg
4.46
3Y Avg
5.74
5Y Avg
7.97
Market Cap
$2.09B
Quick Ratio (Acid-Test)
0.96
TTM Avg
0.99
3Y Avg
1.34
5Y Avg
1.34
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alvotech (ALVO) | $2.05B | 0.96 | 1.00 | 0.89 | 0.89 |
| BioCryst Pharmaceuticals, Inc. (BCRX)vs › | $2.07B | 2.29 | 2.30 | 3.09 | 3.45 |
| Inspire Medical Systems, Inc. (INSP)vs › | $2.06B | 6.16 | 5.39 | 6.60 | 7.52 |
| Addus HomeCare Corporation (ADUS)vs › | $2.13B | 1.69 | 1.73 | 1.64 | 1.89 |
| Immunome, Inc. (IMNM)vs › | $2.04B | 15.08 | 9.38 | 7.12 | 8.07 |
| Aurinia Pharmaceuticals Inc. (AUPH)vs › | $2.03B | 4.97 | 4.46 | 5.74 | 7.97 |
| Fortrea Holdings Inc. (FTRE)vs › | $2.09B | 0.96 | 0.99 | 1.34 | 1.34 |
| AxoGen, Inc. (AXGN)vs › | $2.00B | 5.04 | 2.74 | 2.74 | 3.55 |
| Azenta, Inc. (AZTA)vs › | $2.01B | 2.21 | 3.08 | 5.65 | 4.53 |
| Celldex Therapeutics, Inc. (CLDX)vs › | $2.17B | 11.82 | 14.70 | 15.08 | 16.52 |
Quick Ratio
0.96
Excludes inventory
Current Ratio
1.65
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 0.96 |
| 2026-03-31 | 0.88 |
| 2025-12-31 | 1.16 |
| 2025-09-30 | 0.74 |
| 2025-06-30 | 1.27 |
| 2025-03-31 | 1.19 |
| 2024-12-31 | 1.69 |
| 2024-09-30 | 1.92 |
| 2024-06-30 | 0.16 |
| 2024-03-31 | 0.81 |
| 2023-12-31 | 0.46 |
| 2023-08-31 | 0.78 |
| 2023-06-30 | 0.60 |
| 2023-03-31 | 1.21 |
| 2022-12-31 | 0.95 |
| 2022-09-30 | 0.43 |
| 2022-06-30 | 0.66 |
| 2022-03-31 | 0.10 |
| 2021-12-31 | 0.72 |
| 2021-09-30 | -2.46 |
| 2021-06-30 | 1.02 |
| 2021-03-31 | 1.80 |
| 2020-12-31 | 1.50 |
| 2020-09-30 | 21.37 |
| 2020-06-30 | 1.50 |
| 2020-03-31 | 1.50 |
| 2019-12-31 | 0.00 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
